乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>OB/Gyn >

Breast Cancer

News, opinions and meeting coverage in obstetrics and gynecology.

<乌鸦传媒>NCCN Guideline: No Ink on Tumor Suffices in Breast Cancer Tx

New NCCN guidelines discourage centimeter-wide margins

<乌鸦传媒>CDK 4/6 Inhibitor Makes the Cut in NCCN Breast Ca Guidelines

Ibrance plus AI or ER antagonist generates 'enthusiasm'

<乌鸦传媒>MSK Cancer Alliance: Mainly About Medicine

Bi-directional relationship strengthens regional cancer care

<乌鸦传媒>ECC Roundup: Breast Conservation Benefit Varies by Age

And other reports from the European Cancer Congress

<乌鸦传媒>3D Mammo Ups Cancer Detection in Women Under Age 50

But tomosynthesis is not without its hassles, expert warns

<乌鸦传媒>ESC: Beta-Blocker Cuts Early Heart Damage from Cancer Tx?

No clinical difference in small trial, but preclinical measures suggestive

<乌鸦传媒>Make the Diagnosis: Leg Lesion Teaser

Case Findings: A 47-year-old woman undergoing chemotherapy for breast cancer noticed several red, flaccid bullae on her leg. She was also experiencing fever, cough, and shortness of breath, which developed quickly, so she went to the ED. What is your diagnosis?

<乌鸦传媒>New Trial 'Justifies' FDA Nod for Ibrance

Phase III study had almost identical results as pivotal trial

<乌鸦传媒>Widely Used Breast Chemo Regimen Falls Short

Taxane-cyclophosphamide regimens fail against taxane-anthracycline combinations

<乌鸦传媒>Study: Minorities Less Likely to Get Ca Risk Management

Less genetic testing, bilateral mastectomy in black BRCA carriers

<乌鸦传媒>Longer Letrozole Equals Less BRCA Recurrence

Study suggests that 10 years is better than five

<乌鸦传媒>Trastuzumab Biosimilar Shows Similar Effects

Near-copy of Herceptin may improve global access to treatment

<乌鸦传媒>Friday Feedback: How Safe Is Vaginal Estrogen for Breast Cancer Survivors?

ACOG endorsed its use, but what do experts think?

<乌鸦传媒>ACOG: Vaginal Estrogen Safe for Breast Ca Survivors

No increased risk of cancer recurrence

<乌鸦传媒>Slippery Slope: A Targeted Therapy That Misses the Mark?

Afinitor racks up FDA approvals, but where is the evidence?

<乌鸦传媒>Clear Health Costs: Having Insurance Doesn't Always Pay

The case of the $1,700 mammogram

<乌鸦传媒>Susan G. Komen Founder Steps Out of Spotlight

Nancy Brinker says she won't forget her "promise" to the breast cancer community

<乌鸦传媒>Bone Drugs Equal as Breast Cancer Therapies

Little difference seen among bisphosphonates as cancer fighters.

<乌鸦传媒>Ibrance Delivers in Advanced Breast Ca

Palbociclib-fulvestrant combo leads to better PFS as second-line therapy

<乌鸦传媒>ASCO: Annual Meeting Emphasizes Advances, Challenges in Cancer

Largest program to date highlights developments in breast cancer, other malignancies

<乌鸦传媒>Part 2: Oncologists Weigh In on PBS Cancer Documentary

Six specialists share their impressions of Ken Burns' cancer opus.

<乌鸦传媒>Frankie the Dog Fetches - and Finds Thyroid Cancer?

Canine trained in cancer scent detection gives few false positives in early test.

<乌鸦传媒>Mammograms: Less Pain, Risk-Based Screens?

Breast cancer screening after 40, a more comfortable mammogram.

<乌鸦传媒>Evolution: Breast Reconstruction After Mastectomy

Techniques have changed and improved.

<乌鸦传媒>BCS: 'Jolie Effect' Drives Genetic Test Referrals

SAN FRANCISCO -- Referrals for genetic testing almost doubled in the first 6 months after actress Angelina Jolie said she would undergo bilateral mastectomy after testing positive for BRCA1 mutation.

<乌鸦传媒>Tamoxifen Found in Bodybuilding Supplement

British researchers have found tamoxifen in supplements used by bodybuilders -- an active ingredient that isn't clearly labeled on the bottle.

<乌鸦传媒>Bodybuilders Bulk Up Using ... Cancer Drugs?

While steroids are all-stars among performance-enhancing drugs, breast cancer drugs are a lesser-known staple of doping regimens, as are some investigational agents that aren't available on any regulated market.

<乌鸦传媒>Arimidex: Top Drug for Breast Ca Prevention?

SAN ANTONIO -- Should anastrozole (Arimidex) be the first choice in pharmacologic primary prevention of breast cancer, based on IBIS-II trial results presented here? No, said most experts.

<乌鸦传媒>FDA: Nipple Test No Substitute for Mammogram

A nipple aspirate test shouldn't take the place of mammography or otherwise be used on its own to screen for breast disease, the FDA warned.

<乌鸦传媒>Morning Break: Addictive Oreos and Sperm-Slaying Bacon

Health news and commentary from around the Web, gathered by the 乌鸦传媒 staff.

<乌鸦传媒>Medicare to Pay for More FDG-PET Scans

WASHINGTON -- Up to three scans using 18F-fluorodeoxyglucose-enhanced positron emission tomography technology can be covered by Medicare for oncology treatment planning, the Centers for Medicare and Medicaid Services said.

<乌鸦传媒>ASCO: Two Taxol Regimens Similar in Breast Cancer

CHICAGO -- Breast cancer patients obtained the same disease control with less toxicity when they received weekly low-dose chemotherapy instead of a higher dose given every 2 weeks, results of a randomized trial showed.

<乌鸦传媒>Metformin Role in Breast Cancer Still Unclear

SAN ANTONIO -- Clinical trials of the diabetes drug metformin in breast cancer yielded a few possible clues to anticancer activity but little else, according to a series of reports.

<乌鸦传媒>Effexor May Not Mix with Tamoxifen

SAN ANTONIO -- The antidepressant venlafaxine (Effexor), often given to breast cancer patients to treat the hot flashes associated with tamoxifen therapy, might reduce the effectiveness of the drug, a researcher said here.

<乌鸦传媒>Statins May Slow Inflammatory Breast Cancer

SAN ANTONIO -- Inflammatory breast cancer grew significantly more slowly in women who had a history of treatment with statin drugs, findings from a large retrospective review showed.

<乌鸦传媒>Repeat CT Scans May Up Breast Ca Risk in Young Women

CHICAGO -- A female teenager who undergoes multiple chest or cardiac CT studies may see her 10-year risk for breast cancer double, researchers said here.

<乌鸦传媒>'Scatter' Effects of Mammography Pose Little Risk

CHICAGO -- Scatter radiation from screening mammography is minimal, even to the thyroid, and results in negligible risk to the patient, researchers reported here.

<乌鸦传媒>Study Counters WHI on Risk of Hormones in Menopause

Hormone therapy may actually help the heart in some respects for newly menopausal women, a randomized trial showed, although the impact on hard outcomes like stroke and breast cancer still remains to be seen.

<乌鸦传媒>Drug Works in AI-Resistant Breast Cancer

SAN FRANCISCO -- A tamoxifen-like drug slowed progression of advanced breast cancer previously treated with a nonsteroidal aromatase inhibitor, results of a small Japanese trial suggested.

<乌鸦传媒>Afinitor Helps Breast Tx in Older Patients

SAN FRANCISCO -- Older patients with advanced breast cancer had significant improvement in progression-free survival when everolimus was added to exemestane, a new analysis of a randomized trial showed.

鈥�

11